Skip to content
Saturday 29 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,824.26
+0.29%
DAX
26,569.99
+0.77%
CAC 40
8,401.18
+0.98%
STOXX 50
6,485.67
+0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE

Businesswire

  • iBase-t Announces Strategic Growth Investment from TA to Accelerate AI-Powered Digital Manufacturing and MRO Transformation in Aerospace & Defense

    March 31, 2026

    iBase-t, a leading provider of Manufacturing Operations Management software for aerospace and defense manufacturers, today announced a strategic growth investment from TA Associates (TA), a global growth private equity firm. The investment will support iBase-t’s continued product innovation and global expansion as global aerospace and defense manufacturers scale production, modernize sustainment operations, and accelerate adoption [...]

  • ECCEUKCH: The First Year of Activities to Promote European Extra Virgin Olive Oil in the UK and Switzerland Comes to a Close

    March 31, 2026

    The first year of ECCEUKCH – The Excellence of European Olive Growing in the UK and Switzerland, the three-year information and promotion programme dedicated to high-quality European extra virgin olive oil, co-financed by the European Union under Regulation (EU) No 1144/2014, has come to an end. Promoted by the Tuscan Association of Olive Growers OL.MA. [...]

  • Fresha Becomes the Software Infrastructure of Choice for Multi-location Selfcare Businesses as Enterprise Growth Surges

    March 31, 2026

    Fresha, the top-rated AI-powered booking platform for beauty and wellness, is witnessing significant enterprise growth as multi-location and large-team businesses increasingly choose Fresha to manage and scale their operations. Leading well-established brands, including Menspire, Ted’s Grooming Room, Gould Barbers, Masaj, Adams Barbers, The Art of Nails, and more, are among a growing cohort of enterprise [...]

  • Thermochemical Energy Storage Leader Redoxblox Rebrands as Tempo

    March 31, 2026

    Breaking the heat barrier: Tempo advances towards commercial rollout of continuously delivered electrified industrial heat at up to 1,200°C

  • Allshares Acquires Technology Company Amalia to Accelerate Innovation in Ownership and Incentive Management

    March 31, 2026

    Allshares, a global equity and ownership management platform, today announced the acquisition of Amalia, a France-based company specializing in sales commission and performance management software. The acquisition strengthens Allshares’ platform, adding a sophisticated, rules-based engine that expands and enhances its end-to-end ownership offering. Founded in 2020, Amalia was built technology-first. Its software is centered on [...]

  • Alfasigma Reports Solid Performance in 2025 Supported by Double-Digit Revenue Growth in key strategic brands in Immunology (+17%1), Gastroenterology (+15%), Vascular (+10%), and Consumer Healthcare expansion portfolio in international markets

    March 31, 2026

    Revenues of €1.8 billion (-4% versus PY) driven by solid performance across key therapeutic areas and global markets, partially offset by Ocaliva® withdrawal impact. Adjusted EBITDA2 of €350 million (-18% versus PY) underpinned by streamlined operational efficiencies and operating model evolution. Like-for-like Revenues up 7%, and EBITDA up 20%, adjusted for voluntarily withdrawal of Ocaliva® from US market. Marketing application under EMA review for the use of Jyseleca® in a new indication of axial spondyloarthritis (axSpA), a chronic inflammatory arthritis, to address unmet patient needs, submitted following the reporting period. Following the reporting period, agreement with GSK plc for worldwide exclusive rights to develop, manufacture and commercialise linerixibat; subsequently granted FDA approval for the US market (March 2026).

  • AviadoBio Advances AVB-101 Gene Therapy Program and Initiates Fourth Dose-Escalation Cohort of Phase 1/2 ASPIRE-FTD Trial

    March 31, 2026

    Early biomarker and safety data show encouraging signals with plans to present additional data in 2H 2026 AviadoBio secures strategic investment from The Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) through their Treat FTD Fund to support ASPIRE-FTD Trial AviadoBio regains full rights to AVB-101 gene therapy program

  • FuneralExperts.com Joins Forces with NotifyNOW and InheritNOW to Transform Support for Bereaved Families Across the UK

    March 31, 2026

    FuneralExperts.com, the UK’s leading independent and impartial frontline bereavement support service, has announced a new partnership with The Estate Registry’s services NotifyNOW and InheritNOW to transform the way families are supported following a death – helping them notify organisations efficiently and access vital financial assistance before probate is granted. Through the partnership, families supported by [...]

  • Provation Introduces Real-Time, AI-Powered Documentation Assist for GI Procedures

    March 30, 2026

    Provation, a leading provider of clinical productivity software, announces the launch of Provation® Mira Documentation Assist, a voice-driven documentation capability within its cloud-based GI procedure platform, Provation® Apex, enabling real-time structured documentation during procedures. This hands-free technology allows clinicians to document in real-time by simply speaking, reducing the need for manual data entry and post-procedure [...]

  • Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote

    March 30, 2026

    Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased. Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks. Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority.

Posts pagination

  • Previous
  • Page 1
  • …
  • Page 118
  • Page 119
  • Page 120
  • Page 121
  • Page 122
  • …
  • Page 229
  • Next

Trending Articles

  • Pensioners to hand over bank statements in government benefits crackdown

  • Jamie Carragher: HMRC petitions for Sky Sports star to be declared bankrupt

  • Brewdog founder James Watt hits out at ‘total silence’ over new venture

  • Jamie Vardy bags Bundesliga rights as he steps up streaming war with Neville and Lineker

  • Lloyds Bank and Halifax users unable to use app in latest outage

MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook